Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: A pilot study

Endocrine

Volumn 46, Issue 3, 2014, Pages 585-593

  Yedinak, Chris G ^a,b   Fleseriu, Maria ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acromegaly; Cognition; Concentration; Growth hormone; Memory; Pituitary adenoma

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; SOMATOSTATIN DERIVATIVE; TETRACOSACTIDE;

ACROMEGALY; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE SEVERITY; DISTRACTIBILITY; FEMALE; FUNCTIONAL STATUS; GROWTH HORMONE SECRETING ADENOMA; HEALTH STATUS; HUMAN; LEARNING; MALE; MEMORY; MENTAL CONCENTRATION; MENTAL PERFORMANCE; NONFUNCTIONING PITUITARY ADENOMA; PATIENT PERCEPTION; PERCEPTION; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECALL; ADENOMA; COGNITION DISORDERS; COMPLICATION; HYPOPHYSIS TUMOR; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; SELF CONCEPT;

ACROMEGALY; ADENOMA; COGNITION; COGNITION DISORDERS; FEMALE; HEALTH STATUS; HUMANS; MALE; MEMORY; MIDDLE AGED; PILOT PROJECTS; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT;

EID: 84904581653     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0106-9     Document Type: Article

References (40)

1. K. Aghakhani, M. Kadivar, S. Kazemi-Esfeh, N. Zamani, M. Moradi, H. Sanaei-Zadeh, Prevalence of pituitary incidentaloma in the Iranian cadavers. Indian J. Pathol. Microbiol. 54(4), 692-694 (2011). doi:10.4103/0377-4929.91493
2. S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas: a systematic review. Cancer 101(3), 613-619 (2004). doi:10.1002/cncr.20412
3. S. Melmed, F.F. Casanueva, F. Cavagnini, P. Chanson, L. Frohman, A. Grossman, K. Ho, D. Kleinberg, S. Lamberts, E. Laws, G. Lombardi, M.L. Vance, K.V. Werder, J. Wass, A. Giustina, Guidelines for acromegaly management. J. Clin. Endocrinol. Metab. 87 (9), 4054-4058 (2002)
4. A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege. Belgium. J Clin Endocrinol. Metab. 91(12), 4769-4775 (2006). doi:10.1210/jc.2006-1668
5. A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. (Oxf.) 72(3), 377-382 (2010). doi:10.1111/j.1365-2265.2009.03667.x
6. N.R. Biermasz, J.A. Romijn, A.M. Pereira, F. Roelfsema, Current pharmacotherapy for acromegaly: a review. Expert Opin. Pharmacother. 6(14), 2393-2405 (2005). doi:10.1517/14656566.6.14.2393
7. O.M. Dekkers, N.R. Biermasz, A.M. Pereira, J.A. Romijn, J.P. Vandenbroucke, Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93(1), 61-67 (2008). doi:10.1210/jc.2007-1191
8. I.M. Holdaway, C.R. Rajasoorya, G.D. Gamble, A.W. Stewart, Long-term treatment outcome in acromegaly. Growth Horm. IGF Res. 13(4), 185-192 (2003)
9. S.M. Webb, L. Prieto, X. Badia, M. Albareda, M. Catala, S. Gaztambide, T. Lucas, C. Paramo, A. Pico, A. Lucas, I. Halperin, G. Obiols, R. Astorga, Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. (Oxf.) 57(2), 251-258 (2002)
10. G. Mazziotti, M. Gola, A. Bianchi, T. Porcelli, A. Giampietro, V. Cimino, M. Doga, C. Gazzaruso, L. De Marinis, A. Giustina, Influence of diabetes mellitus on vertebral fractures in men with acromegaly. Endocrine 40 (1), 102-108 (2011). doi:10.1007/ s12020-011-9486-x
11. G. Örük, F. Tarhan, M. Argin, M. Özmen, Is every joint symptom related to acromegaly? Endocrine 43(2), 404-411 (2013). doi:10.1007/s12020-012-9770-4
12. J.A. Romijn, Acromegalic arthropathy: current perspectives. Endocrine 43(2), 245-246 (2013). doi:10.1007/s12020-012-9781-1
13. I.M. Holdaway, C. Rajasoorya, Epidemiology of acromegaly. Pituitary 2(1), 29-41 (1999)
14. S. Melmed, Medical progress: acromegaly. N. Engl. J. Med. 355(24), 2558-2573 (2006). doi:10.1056/NEJMra062453
15. J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W. Smit, J.A. Romijn, N.R. Biermasz, Affected illness perceptions and the association with impaired quality of life in patients with longterm remission of acromegaly. J. Clin. Endocrinol. Metab. 96(11), 3550-3558 (2011). doi:10.1210/jc.2011-1645
16. J.F. Martin-Rodriguez, A. Madrazo-Atutxa, E. Venegas-Moreno, P. Benito-Lopez, M.A. Galvez, D.A. Cano, F.J. Tinahones, E. Torres-Vela, A. Soto-Moreno, A. Leal-Cerro, Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naive acromegaly. PLoS One 8(4), e60041 (2013). doi:10.1371/journal.pone.0060041
17. C. Sievers, P.G. Samann, H. Pfister, C. Dimopoulou, M. Czisch, J. Roemmler, J. Schopohl, G.K. Stalla, J. Zihl, Cognitive function in acromegaly: description and brain volumetric correlates. Pituitary 15(3), 350-357 (2012). doi:10.1007/s11102-011-0326-z
18. F. Tanriverdi, H. Yapislar, Z. Karaca, K. Unluhizarci, C. Suer, F. Kelestimur, Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm. IGF Res. 19(1), 24-30 (2009). doi:10.1016/j.ghir.2008. 05.002
19. A. Tooze, C.L. Hiles, J.P. Sheehan, Neurocognitive changes in pituitary adenoma patients after gamma knife radiosurgery: a preliminary study. World Neurosurg. 78 (1-2), 122-128 (2012). doi:10.1016/j.wneu.2011.09.010
20. P.S. van Dam, A. Aleman, W.R. de Vries, J.B. Deijen, E.A. van der Veen, E.H. de Haan, H.P. Koppeschaar, Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm. IGF Res. 10(Suppl B), S69-S73 (2000)
21. M. Bleuler, Personality changes in pituitary disorders. Br. Med. J. 1(4706), 580-581 (1951)
22. J. Leon-Carrion, J.F. Martin-Rodriguez, A. Madrazo-Atutxa, A. Soto-Moreno, E. Venegas-Moreno, E. Torres-Vela, P. Benito-Lopez, M.A. Galvez, F.J. Tinahones, A. Leal-Cerro, Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J. Clin. Endocrinol. Metab. 95(9), 4367-4379 (2010). doi:10.1210/jc.2010-0394
23. K. Mussig, B. Besemer, R. Saur, S. Klingberg, H.U. Haring, B. Gallwitz, T. Leyhe, Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients. J. Int. Neuropsychol. Soc. 17(2), 369-375 (2011). doi:10.1017/S1355617710001645
24. J. Tiemensma, N.R. Biermasz, R.C. van der Mast, M.J. Wassenaar, H.A. Middelkoop, A.M. Pereira, J.A. Romijn, Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J. Clin. Endocrinol. Metab. 95(12), E392-E402 (2010). doi:10.1210/jc.2010-1253
25. J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W. Smit, J.A. Romijn, N.R. Biermasz, Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas. J. Clin. Endocrinol. Metab. 96(4), 964-971 (2011). doi:10.1210/ jc.2010-2490
26. M.G. Falleti, P. Maruff, P. Burman, A. Harris, The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 31 (6), 681-691 (2006). doi:10.1016/j.psyneuen.2006.01.005
27. K.K. Ho, Diagnosis and management of adult growth hormone deficiency. Endocrine 12(2), 189-196 (2000). doi:10.1385/ENDO:12:2:189
28. L. Katznelson, J.L. Atkinson, D.M. Cook, S.Z. Ezzat, A.H. Hamrahian, K.K. Miller, American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update. Endocr. Pract. 17(Suppl 4), 1-44 (2011)
29. A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95(7), 3141-3148 (2010). doi:10.1210/jc.2009-2670
30. S. Melmed, F.F. Casanueva, A. Klibanski, M.D. Bronstein, P. Chanson, S.W. Lamberts, C.J. Strasburger, J.A. Wass, A. Giustina, A consensus on the diagnosis and treatment of acromegaly complications. Pituitary (2012). doi:10.1007/s11102-012-0420-x
31. L.I. Wagner, S.R. Berg, M. Gandhi, F.J. Hlubocky, K. Webster, M. Aneja, D. Cella, M.E. Lacouture, The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18). Support. Care Cancer 21 (4), 1033-1041 (2013). doi:10.1007/s00520-012-1623-4
32. P. Brummelman, J. Koerts, R.P. Dullaart, G. van den Berg, O. Tucha, B.H. Wolffenbuttel, A.P. van Beek, Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur. J. Clin. Invest. 42(12), 1317-1324 (2012). doi:10.1111/j.1365-2362.2012.02721.x
33. Ayuk, J., Radiotherapy, cognition and cerebrovascular disease: What is the evidence?. Endocrine Abstracts 25, CM3.4 (2011)
34. R. Rola, J. Raber, A. Rizk, S. Otsuka, S.R. VandenBerg, D.R. Morhardt, J.R. Fike, Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp. Neurol. 188(2), 316-330 (2004). doi:10.1016/j. expneurol.2004.05.005
35. A.M. Pereira, J. Tiemensma, J.A. Romijn, N.R. Biermasz, Cognitive impairment and psychopathology in patients with pituitary diseases. Neth. J. Med. 70(6), 255-260 (2012)
36. A. Cohen, R.I. Ivry, S.W. Keele, Attention and structure in sequence learning. J. Exp. Psychol. Learn. Mem. Cogn. 16(1), 17-30 (1990). doi:10.1037/0278-7393.16.1.17
37. S. Grossberg, Linking attention to learning, expectation, competition, and consciousness. Technical report CAS/CNS TR-2003-007, in Neurobiology of attention, ed. by L. Itti, G. Rees, J. Tsotsos (Elsevier, San Diego, 2005), pp. 652-666
38. M. Fleseriu, Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary 14(2), 184-193 (2011). doi:10.1007/s11102-010-0282-z
39. C. Sardella, M. Lombardi, G. Rossi, C. Cosci, S. Brogioni, I. Scattina, S.M. Webb, M. Gasperi, E. Martino, F. Bogazzi, Shortand long-term changes of quality of life in patients with acromegaly: results from a prospective study. J. Endocrinol. Invest. 33(1), 20-25 (2010)
40. J. Walter, S. Keiner, O.W. Witte, C. Redecker, Age-related effects on hippocampal precursor cell subpopulations and neurogenesis. Neurobiol. Aging 32(10), 1906-1914 (2011). doi:10.1016/j.neurobiolaging.2009.11.011